JP2022500351A5 - - Google Patents

Info

Publication number
JP2022500351A5
JP2022500351A5 JP2020567621A JP2020567621A JP2022500351A5 JP 2022500351 A5 JP2022500351 A5 JP 2022500351A5 JP 2020567621 A JP2020567621 A JP 2020567621A JP 2020567621 A JP2020567621 A JP 2020567621A JP 2022500351 A5 JP2022500351 A5 JP 2022500351A5
Authority
JP
Japan
Prior art keywords
pharmaceutically acceptable
hydroxypiperidine
bipyridine
methanone
benzyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020567621A
Other languages
English (en)
Japanese (ja)
Other versions
JP7443255B2 (ja
JP2022500351A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2019/038061 external-priority patent/WO2020059894A1/en
Publication of JP2022500351A publication Critical patent/JP2022500351A/ja
Publication of JP2022500351A5 publication Critical patent/JP2022500351A5/ja
Application granted granted Critical
Publication of JP7443255B2 publication Critical patent/JP7443255B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020567621A 2018-09-20 2019-09-19 疼痛使用のためのｃｈ２４ｈ阻害剤 Active JP7443255B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862733927P 2018-09-20 2018-09-20
US62/733,927 2018-09-20
PCT/JP2019/038061 WO2020059894A1 (en) 2018-09-20 2019-09-19 CH24H Inhibitors For Pain Use

Publications (3)

Publication Number Publication Date
JP2022500351A JP2022500351A (ja) 2022-01-04
JP2022500351A5 true JP2022500351A5 (https=) 2022-09-20
JP7443255B2 JP7443255B2 (ja) 2024-03-05

Family

ID=68343384

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020567621A Active JP7443255B2 (ja) 2018-09-20 2019-09-19 疼痛使用のためのｃｈ２４ｈ阻害剤

Country Status (4)

Country Link
US (1) US20210346366A1 (https=)
EP (1) EP3852757A1 (https=)
JP (1) JP7443255B2 (https=)
WO (1) WO2020059894A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025126159A1 (en) * 2023-12-15 2025-06-19 Takeda Pharmaceutical Company Limited A method for treating a neurological disease in a recreational drug user

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP2014007606A0 (en) 2011-10-07 2014-05-31 Takeda Pharmaceutical 1-Arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases
WO2013056229A1 (en) 2011-10-14 2013-04-18 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services The use of (2r, 6r)-hydroxynorketamine, (s)-dehydronorketamine and other stereoisomeric dehydro and hydroxylated metabolites of (r,s)- ketamine in the treatment of depression and neuropathic pain
HUE039922T2 (hu) 2012-12-11 2019-02-28 Takeda Pharmaceuticals Co Heterociklusos vegyületek
CN119269811A (zh) * 2013-03-13 2025-01-07 萨奇治疗股份有限公司 神经活性类固醇、组合物、及其用途
EP2982666B1 (en) * 2013-04-04 2019-08-07 Takeda Pharmaceutical Company Limited Heterocyclic compound
CA2951521A1 (en) 2014-06-09 2015-12-17 Takeda Pharmaceutical Company Limited Radiolabeled compounds

Similar Documents

Publication Publication Date Title
US10633413B2 (en) Methods of treating Parkinson's disease using aminosterols and compositions comprising the same
JP2024530310A (ja) Ｔ細胞リンパ腫治療薬の調製におけるｅｚｈ２阻害剤の使用
US12102637B2 (en) Pharmaceutical formulations for treating endometriosis, uterine fibroids, polycystic ovary syndrome or adenomyosis
MX2010005680A (es) Composiciones de tapentadol.
HUE029677T2 (hu) Készítmények centrálisan mediált émelygés és hányás kezelésére
CN106999593A (zh) 用于纤维化治疗的赛尼克韦罗组合疗法
US20190054088A1 (en) Pharmaceutical Formulations for Treating Endometriosis, Uterine Fibroids, Polycystic Ovary Syndrome or Adenomyosis
AU2015301097A1 (en) Drug combinations to treat multiple myeloma
CA3034875C (en) Combination therapies for the treatment of hepatocellular carcinoma
JP5757544B2 (ja) 癌治療に用いられるベムラフェニブとインターフェロンを含む併用療法
JP2015517523A5 (https=)
JP2025060685A (ja) ピリダジノンｔｒｐｃ５阻害剤の噴霧乾燥された製剤
CA2688542C (en) Methods and compositions for administration of oxybutynin
JP2019507786A5 (https=)
JP2022500351A5 (https=)
TW202339731A (zh) 用於治療進行性纖維化間質性肺病之新穎口服醫藥組合物及劑量療法
US11833119B2 (en) Combination therapies for the treatment of hepatocellular carcinoma
JP2020512292A5 (https=)
CN114786647A (zh) 口服药学立即释放组合物和用于重量减轻的治疗方法
JP2021530568A5 (https=)
TW200423929A (en) Pharmaceutical combination
JP2000513349A (ja) パーキンソン病の治療における使用のためのロピニロールおよびｌ―ｄｏｐａの組み合わせ
JP6878021B2 (ja) トリプタンとアスコルビン酸を含有する医薬組成物
EA046645B1 (ru) Фармацевтические препараты для лечения эндометриоза, миомы матки, синдрома поликистоза яичников или аденомиоза